ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - BIT:1LLY - US5324571083 - Common Stock
709.1 EUR
+12.2 (+1.75%)
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 53 industry peers in the Pharmaceuticals industry. While 1LLY has a great profitability rating, there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year 1LLY was profitable.
1LLY had a positive operating cash flow in the past year.
In the past 5 years 1LLY has always been profitable.
Each year in the past 5 years 1LLY had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 13.67%, 1LLY belongs to the best of the industry, outperforming 84.91% of the companies in the same industry.
With an excellent Return On Equity value of 75.52%, 1LLY belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
With an excellent Return On Invested Capital value of 29.63%, 1LLY belongs to the best of the industry, outperforming 94.34% of the companies in the same industry.
1LLY had an Average Return On Invested Capital over the past 3 years of 21.71%. This is significantly above the industry average of 15.19%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(29.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROIC | 29.63% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
Looking at the Profit Margin, with a value of 25.91%, 1LLY belongs to the top of the industry, outperforming 90.57% of the companies in the same industry.
In the last couple of years the Profit Margin of 1LLY has declined.
With an excellent Operating Margin value of 42.13%, 1LLY belongs to the best of the industry, outperforming 94.34% of the companies in the same industry.
In the last couple of years the Operating Margin of 1LLY has grown nicely.
The Gross Margin of 1LLY (82.64%) is better than 84.91% of its industry peers.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1LLY is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
The number of shares outstanding for 1LLY has been reduced compared to 5 years ago.
1LLY has a worse debt/assets ratio than last year.
2.2 Solvency
1LLY has an Altman-Z score of 7.32. This indicates that 1LLY is financially healthy and has little risk of bankruptcy at the moment.
1LLY has a Altman-Z score of 7.32. This is amongst the best in the industry. 1LLY outperforms 94.34% of its industry peers.
A Debt/Equity ratio of 1.87 is on the high side and indicates that 1LLY has dependencies on debt financing.
1LLY has a Debt to Equity ratio of 1.87. This is in the lower half of the industry: 1LLY underperforms 79.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.32 |
ROIC/WACC3.45
WACC8.6%
2.3 Liquidity
1LLY has a Current Ratio of 1.28. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
1LLY has a Current ratio (1.28) which is comparable to the rest of the industry.
1LLY has a Quick Ratio of 1.28. This is a bad value and indicates that 1LLY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1LLY (1.00) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.67%, which is quite impressive.
The Earnings Per Share has been growing by 16.57% on average over the past years. This is quite good.
The Revenue has grown by 36.83% in the past year. This is a very strong growth!
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
3.2 Future
Based on estimates for the next years, 1LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 30.19% on average per year.
The Revenue is expected to grow by 17.70% on average over the next years. This is quite good.
EPS Next Y76.53%
EPS Next 2Y52.79%
EPS Next 3Y41.48%
EPS Next 5Y30.19%
Revenue Next Year36.8%
Revenue Next 2Y27.26%
Revenue Next 3Y23.11%
Revenue Next 5Y17.7%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 51.27, the valuation of 1LLY can be described as expensive.
64.15% of the companies in the same industry are cheaper than 1LLY, based on the Price/Earnings ratio.
1LLY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.42.
1LLY is valuated quite expensively with a Price/Forward Earnings ratio of 27.29.
1LLY's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 69.81% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. 1LLY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.27 | ||
| Fwd PE | 27.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 71.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 33.71 |
4.3 Compensation for Growth
1LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of 1LLY may justify a higher PE ratio.
1LLY's earnings are expected to grow with 41.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)3.09
EPS Next 2Y52.79%
EPS Next 3Y41.48%
5. Dividend
5.1 Amount
1LLY has a yearly dividend return of 0.73%, which is pretty low.
Compared to an average industry Dividend Yield of 3.00, 1LLY has a dividend in line with its industry peers.
With a Dividend Yield of 0.73, 1LLY pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.73% |
5.2 History
The dividend of 1LLY is nicely growing with an annual growth rate of 15.60%!
Dividend Growth(5Y)15.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1LLY pays out 36.46% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP36.46%
EPS Next 2Y52.79%
EPS Next 3Y41.48%
BIT:1LLY (10/15/2025, 7:00:00 PM)
709.1
+12.2 (+1.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap671.13B
Analysts80
Price Target768.2 (8.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.73% |
Yearly Dividend4.22
Dividend Growth(5Y)15.6%
DP36.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.94%
Min EPS beat(2)9.38%
Max EPS beat(2)14.51%
EPS beat(4)3
Avg EPS beat(4)2.5%
Min EPS beat(4)-20.34%
Max EPS beat(4)14.51%
EPS beat(8)7
Avg EPS beat(8)31.01%
EPS beat(12)10
Avg EPS beat(12)22.08%
EPS beat(16)12
Avg EPS beat(16)15.86%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)4.72%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-6.46%
Max Revenue beat(4)4.72%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)1.54%
PT rev (1m)-0.4%
PT rev (3m)-10.68%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)2.76%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)5.04%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)3.93%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)3.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.27 | ||
| Fwd PE | 27.29 | ||
| P/S | 14.72 | ||
| P/FCF | N/A | ||
| P/OCF | 71.67 | ||
| P/B | 42.9 | ||
| P/tB | 118.89 | ||
| EV/EBITDA | 33.71 |
EPS(TTM)13.83
EY1.95%
EPS(NY)25.98
Fwd EY3.66%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)9.89
OCFY1.4%
SpS48.17
BVpS16.53
TBVpS5.96
PEG (NY)0.67
PEG (5Y)3.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROCE | 36.25% | ||
| ROIC | 29.63% | ||
| ROICexc | 31.43% | ||
| ROICexgc | 39.29% | ||
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% | ||
| FCFM | N/A |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexcg growth 3Y1.59%
ROICexcg growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.81%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.4 | ||
| Cap/Depr | 580.51% | ||
| Cap/Sales | 20.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 7.32 |
F-Score6
WACC8.6%
ROIC/WACC3.45
Cap/Depr(3y)374.28%
Cap/Depr(5y)279.43%
Cap/Sales(3y)16.34%
Cap/Sales(5y)12.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
EPS Next Y76.53%
EPS Next 2Y52.79%
EPS Next 3Y41.48%
EPS Next 5Y30.19%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
Revenue Next Year36.8%
Revenue Next 2Y27.26%
Revenue Next 3Y23.11%
Revenue Next 5Y17.7%
EBIT growth 1Y67.12%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y29.64%
FCF growth 1Y-101.56%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y75.24%
OCF growth 3Y6.69%
OCF growth 5Y12.76%